Why Bausch Health Companies Shares Are Falling After Q1 Results - Bausch Health Companies (NYSE:BHC)
Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.
Source: benzinga.com
Stay updated with breaking news from Thomasj Appio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case ...
LAVAL, QC / ACCESSWIRE / April 5, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced that it filed a lawsuit today in
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
The gel is applied to the affected area once daily.